Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT03654105
Eligibility Criteria:
Inclusion Criteria:
* Age between 55 and 75 years
* High consumption of cigarettes (≥ 30 packs/year)
* Elegibility to annual LDCT screening
* Confidence in Internet use
* Absence of tumors for at least 5 years
* Signed informed consent form
Exclusion Criteria:
* Hypersensitivity to acetylsalicylic acid, salicylates or any of the excipients (excipients: cellulose powder, corn starch, coating: copolymers of methacrylic acid, sodium lauryl sulfate, polysorbate 80, talc, triethyl citrate)
* Chronic treatment with acetylsalicylic acid, or other anti-clotting or anti-coagulant drugs (for example: heparin, dicumarol)
* Treatment with methotrexate
* Existing Mastocytosis
* History of asthma induced by the administration of salicylates or substances to similar activity, particularly non-steroidal anti-inflammatory drugs
* Gastroduodenal ulcer
* Hemorrhagic diathesis
* Severe chronic pathology (eg: severe respiratory and / or renal and / or hepatic and / or cardiac insufficiency)
* Serious psychiatric problems
* Previous treatment with Cytisine
* Abuse of alcohol or other substances (even previous)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
75 Years
Study:
NCT03654105
Study Brief:
Protocol Section:
NCT03654105